Correction to: Influence of CYP2C19 genotypes for the effect of 1‑month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12‑month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT‑2
1 Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
2 Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
3 Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
4 Department of Cardiovascular Medicine, Saga University, Saga, Japan.
5 Department of Cardiovascular Medicine, Saiseikai Fukuoka General Hospital, Fukuoka, Japan.
6 Division of Cardiology, Department of Internal Medicine, Memorial Heart Center, Iwate Medical University, Morioka, Japan.
7 Department of Cardiology, Minamino Cardiovascular Hospital, Hachioji, Japan.
8 Department of Cardiology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.
9 Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
10 Department of Internal Medicine, Division of Cardiology, Shimonoseki City Hospital, Shimonoseki, Japan.
11 Department of Cardiology, Chikamori Hospital, Kochi, Japan.
12 Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan.
13 Department of Cardiology, Kimitsu Chuo Hospital, Kisarazu, Japan.
14 Department of Cardiology, Mashiko Hospital, Kawaguchi, Japan.
15 Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
16 Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. taketaka@kuhp.kyoto-u.ac.jp.